Botanical Drug Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Botanical Drug market size was valued at USD 33630 million in 2022 and is forecast to a readjusted size of USD 43740 million by 2029 with a CAGR of 3.8% during review period.

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.

Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry. Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%. The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%. Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.

This report is a detailed and comprehensive analysis for global Botanical Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Botanical Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Botanical Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Botanical Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Botanical Drug market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Botanical Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Botanical Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Buchang Pharmaceuticals
   China TCM
   Tsumura
   Schwabe
   Tong Ren Tang
   Jumpcan Pharmaceutical
   Guangzhou Baiyunshan Pharmaceutical
   Yunnan Baiyao
   Tasly Holding Group
   Bionorica Se
   Huarun 999
   Taiji
   Weleda
   Kwangdong
   GW Pharmaceuticals

   Prescription Drug
   OTC

   Cardiovascular
   Tumor
   Respiratory System
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Botanical Drug Market in 2025?

The increasing consumer demand for natural and plant-based therapies, alongside growing awareness of the potential benefits of botanical medicines, will boost the market. Additionally, regulatory support and advancements in research methods will improve the credibility and safety of botanical drugs.

What are the weaknesses of the Botanical Drug Market in 2025?

Despite the growth, there are concerns about inconsistent product quality, lack of standardized regulations across regions, and the challenges of scaling production. There may also be a lack of sufficient clinical data compared to traditional pharmaceutical drugs, which could limit widespread adoption.

What are the opportunities for the Botanical Drug Market in 2025?

Expanding markets in emerging economies, increasing research funding, and growing demand for sustainable, eco-friendly healthcare solutions present significant opportunities. Collaboration between traditional and modern medicine practices is also an area for potential growth, as well as the development of new botanical compounds.

What are the threats to the Botanical Drug Market in 2025?

There is the risk of over-regulation that may stifle innovation, and competition from synthetic drugs that may be more widely trusted by consumers. Furthermore, issues related to the sustainability of sourcing raw materials, along with potential adverse reactions to unregulated botanical products, could also hinder market growth.

How do political factors impact the Botanical Drug Market in 2025?

Government policies on herbal medicine regulation, intellectual property rights, and international trade agreements will play a crucial role. Supportive policies can drive innovation, while strict regulations may slow down approvals and market entry.

How do economic factors influence the Botanical Drug Market in 2025?

Rising healthcare expenditures, increasing consumer spending on natural remedies, and investments in pharmaceutical R&D will boost the market. However, economic instability and high production costs could pose challenges for manufacturers.

How do social factors affect the Botanical Drug Market in 2025?

Growing consumer preference for plant-based therapies, increasing awareness of holistic medicine, and cultural acceptance of traditional herbal remedies will drive demand. However, skepticism regarding efficacy and safety among certain populations may limit growth.

How do technological factors shape the Botanical Drug Market in 2025?

Advancements in extraction techniques, quality control, and biotechnology are improving the safety and efficacy of botanical drugs. Digital health solutions, such as AI-driven research and personalized medicine, are also accelerating market expansion.

How do environmental factors impact the Botanical Drug Market in 2025?

Sustainability concerns related to the overharvesting of medicinal plants and deforestation could affect raw material availability. Companies are increasingly focusing on ethical sourcing, eco-friendly cultivation, and conservation efforts to mitigate environmental risks.

How do legal factors influence the Botanical Drug Market in 2025?

Stringent regulatory frameworks, patent laws, and evolving global standards for botanical drug approvals will shape the industry. Compliance with different regional regulations remains a challenge for companies seeking global expansion.

Who are the key suppliers in the Botanical Drug Market in 2025?

Suppliers include raw material providers such as herbal farms, botanical extract manufacturers, and biotechnology firms specializing in plant-based compounds. Research institutions and regulatory bodies also play a role in ensuring quality and compliance.

What are the main inputs in the Botanical Drug Market in 2025?

Key inputs include medicinal plants, bioactive compounds, extraction technologies, research data, and regulatory approvals. Investments in R&D and compliance with Good Manufacturing Practices (GMP) are also essential.

What are the core processes in the Botanical Drug Market in 2025?

The process involves raw material sourcing, extraction and purification of active compounds, formulation development, clinical trials, regulatory approvals, manufacturing, packaging, and distribution. Quality assurance and safety testing are critical at every stage.

Who are the primary outputs in the Botanical Drug Market in 2025?

Outputs include approved botanical drugs, over-the-counter herbal formulations, prescription-based botanical medicines, and research publications validating efficacy and safety. Market reports and regulatory guidelines are also key outputs.

Who are the key customers in the Botanical Drug Market in 2025?

Customers range from pharmaceutical companies, hospitals, and healthcare providers to individual consumers seeking natural alternatives. Government agencies, research institutions, and wellness brands also contribute to demand.

How strong is the threat of new entrants in the Botanical Drug Market in 2025?

The threat is moderate. While the growing demand for natural medicines attracts new players, high R&D costs, stringent regulatory approvals, and the need for quality standardization create significant entry barriers.

How intense is the bargaining power of suppliers in the Botanical Drug Market in 2025?

Suppliers hold moderate to high power, especially for rare or sustainably sourced botanical ingredients. Dependence on specific plant sources and the need for ethical sourcing practices can drive up costs and limit supply options.

How strong is the bargaining power of buyers in the Botanical Drug Market in 2025?

Buyers have moderate power due to increasing awareness and demand for botanical drugs. However, concerns over efficacy, safety, and price sensitivity mean that consumers and healthcare providers carefully evaluate product choices before making purchases.

How intense is the threat of substitutes in the Botanical Drug Market in 2025?

The threat is high, as synthetic pharmaceuticals, dietary supplements, and traditional herbal remedies all compete with botanical drugs. The choice often depends on consumer trust, clinical validation, and regulatory approvals.

How competitive is the rivalry among existing players in the Botanical Drug Market in 2025?

Competition is high, with pharmaceutical giants, biotech firms, and traditional herbal medicine companies all striving for market share. Differentiation through clinical validation, sustainable sourcing, and innovation in formulations is key to staying ahead.

What are the key raw materials required in the Botanical Drug Market in 2025?

The primary raw materials include medicinal plants, herbal extracts, bioactive compounds, and solvents used in extraction. Sustainable sourcing and quality control of these materials are critical for drug efficacy and regulatory approval.

Who are the major suppliers in the upstream segment of the Botanical Drug Market in 2025?

Suppliers include herbal farms, botanical extract manufacturers, biotech firms specializing in plant-based compounds, and agricultural cooperatives. Some pharmaceutical companies also invest in direct sourcing to ensure consistent supply and quality.

What are the key challenges in the upstream supply chain of the Botanical Drug Market in 2025?

Challenges include the risk of overharvesting, climate change affecting plant yields, supply chain disruptions, and fluctuating costs of raw materials. Regulatory compliance for sustainable sourcing and Good Agricultural Practices (GAP) adds another layer of complexity.

How does technology impact the upstream segment of the Botanical Drug Market in 2025?

Advanced extraction techniques, biotechnology applications, and AI-driven quality control are improving raw material processing. Innovations in plant cultivation, such as vertical farming and hydroponics, are helping ensure a stable and sustainable supply.

How do regulations affect the upstream supply chain in the Botanical Drug Market in 2025?

Regulatory frameworks mandate strict quality control, traceability, and sustainability practices for raw material sourcing. Compliance with guidelines like Good Agricultural and Collection Practices (GACP) and international botanical drug standards influences supplier operations.

What are the key processes involved in the midstream segment of the Botanical Drug Market in 2025?

The midstream segment includes extraction, purification, formulation, clinical trials, and regulatory approval. Ensuring consistency in active compounds and meeting safety standards are critical steps before commercialization.

Who are the major players in the midstream segment of the Botanical Drug Market in 2025?

Key players include pharmaceutical companies, biotech firms, contract manufacturing organizations (CMOs), and research institutions. These entities focus on developing standardized botanical formulations and securing regulatory approvals.

What are the biggest challenges in the midstream segment of the Botanical Drug Market in 2025?

Challenges include maintaining batch-to-batch consistency, meeting stringent regulatory requirements, and conducting expensive clinical trials. Limited clinical data compared to synthetic drugs can slow down the approval process.

How does technology influence the midstream segment of the Botanical Drug Market in 2025?

Technologies such as AI-driven drug discovery, advanced chromatography, and precision fermentation are enhancing the standardization and efficacy of botanical drugs. Digital tools also streamline regulatory documentation and clinical trial management.

How do regulations impact the midstream segment of the Botanical Drug Market in 2025?

Regulations ensure product safety, efficacy, and quality, but compliance is complex due to varying global standards. Adhering to Good Manufacturing Practices (GMP) and gaining FDA, EMA, or other regulatory approvals are essential for market entry.

Who are the key distributors in the downstream segment of the Botanical Drug Market in 2025?

Distributors include pharmaceutical wholesalers, online marketplaces, retail pharmacies, and specialized herbal medicine stores. Hospitals and clinics also serve as major distribution channels for prescription-based botanical drugs.

What are the main challenges in the downstream segment of the Botanical Drug Market in 2025?

Challenges include regulatory hurdles in different markets, the need for physician and consumer education, and competition from synthetic drugs and dietary supplements. Ensuring cold chain logistics for certain botanical formulations is also a concern.

How do consumers influence the downstream segment of the Botanical Drug Market in 2025?

Growing consumer preference for plant-based medicine, demand for transparency in sourcing, and increased interest in self-care drive market trends. However, concerns over efficacy, safety, and standardization impact purchasing decisions.

What role does marketing play in the downstream segment of the Botanical Drug Market in 2025?

Effective marketing strategies include scientific endorsements, digital campaigns, and partnerships with healthcare professionals. Companies focus on building consumer trust through clinical evidence, sustainability claims, and product certifications.

How does regulation impact the downstream segment of the Botanical Drug Market in 2025?

Regulatory requirements influence labeling, advertising, and distribution strategies. Compliance with different regional guidelines is essential to prevent legal challenges and ensure consumer safety.

Chapter 1, to describe Botanical Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Botanical Drug, with revenue, gross margin and global market share of Botanical Drug from 2018 to 2023.
Chapter 3, the Botanical Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Botanical Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Botanical Drug.
Chapter 13, to describe Botanical Drug research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Botanical Drug
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Botanical Drug by Type
       1.3.1 Overview: Global Botanical Drug Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Botanical Drug Consumption Value Market Share by Type in 2022
       1.3.3 Prescription Drug
       1.3.4 OTC
   1.4 Global Botanical Drug Market by Application
       1.4.1 Overview: Global Botanical Drug Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Cardiovascular
       1.4.3 Tumor
       1.4.4 Respiratory System
       1.4.5 Others
   1.5 Global Botanical Drug Market Size & Forecast
   1.6 Global Botanical Drug Market Size and Forecast by Region
       1.6.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Botanical Drug Market Size by Region, (2018-2029)
       1.6.3 North America Botanical Drug Market Size and Prospect (2018-2029)
       1.6.4 Europe Botanical Drug Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Botanical Drug Market Size and Prospect (2018-2029)
       1.6.6 South America Botanical Drug Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Botanical Drug Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Buchang Pharmaceuticals
       2.1.1 Buchang Pharmaceuticals Details
       2.1.2 Buchang Pharmaceuticals Major Business
       2.1.3 Buchang Pharmaceuticals Botanical Drug Product and Solutions
       2.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Buchang Pharmaceuticals Recent Developments and Future Plans
   2.2 China TCM
       2.2.1 China TCM Details
       2.2.2 China TCM Major Business
       2.2.3 China TCM Botanical Drug Product and Solutions
       2.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 China TCM Recent Developments and Future Plans
   2.3 Tsumura
       2.3.1 Tsumura Details
       2.3.2 Tsumura Major Business
       2.3.3 Tsumura Botanical Drug Product and Solutions
       2.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Tsumura Recent Developments and Future Plans
   2.4 Schwabe
       2.4.1 Schwabe Details
       2.4.2 Schwabe Major Business
       2.4.3 Schwabe Botanical Drug Product and Solutions
       2.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Schwabe Recent Developments and Future Plans
   2.5 Tong Ren Tang
       2.5.1 Tong Ren Tang Details
       2.5.2 Tong Ren Tang Major Business
       2.5.3 Tong Ren Tang Botanical Drug Product and Solutions
       2.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Tong Ren Tang Recent Developments and Future Plans
   2.6 Jumpcan Pharmaceutical
       2.6.1 Jumpcan Pharmaceutical Details
       2.6.2 Jumpcan Pharmaceutical Major Business
       2.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Solutions
       2.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
   2.7 Guangzhou Baiyunshan Pharmaceutical
       2.7.1 Guangzhou Baiyunshan Pharmaceutical Details
       2.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
       2.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
       2.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
   2.8 Yunnan Baiyao
       2.8.1 Yunnan Baiyao Details
       2.8.2 Yunnan Baiyao Major Business
       2.8.3 Yunnan Baiyao Botanical Drug Product and Solutions
       2.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Yunnan Baiyao Recent Developments and Future Plans
   2.9 Tasly Holding Group
       2.9.1 Tasly Holding Group Details
       2.9.2 Tasly Holding Group Major Business
       2.9.3 Tasly Holding Group Botanical Drug Product and Solutions
       2.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Tasly Holding Group Recent Developments and Future Plans
   2.10 Bionorica Se 
       2.10.1 Bionorica Se Details
       2.10.2 Bionorica Se Major Business
       2.10.3 Bionorica Se Botanical Drug Product and Solutions
       2.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Bionorica Se Recent Developments and Future Plans
   2.11 Huarun 999
       2.11.1 Huarun 999 Details
       2.11.2 Huarun 999 Major Business
       2.11.3 Huarun 999 Botanical Drug Product and Solutions
       2.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Huarun 999 Recent Developments and Future Plans
   2.12 Taiji
       2.12.1 Taiji Details
       2.12.2 Taiji Major Business
       2.12.3 Taiji Botanical Drug Product and Solutions
       2.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Taiji Recent Developments and Future Plans
   2.13 Weleda
       2.13.1 Weleda Details
       2.13.2 Weleda Major Business
       2.13.3 Weleda Botanical Drug Product and Solutions
       2.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Weleda Recent Developments and Future Plans
   2.14 Kwangdong
       2.14.1 Kwangdong Details
       2.14.2 Kwangdong Major Business
       2.14.3 Kwangdong Botanical Drug Product and Solutions
       2.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Kwangdong Recent Developments and Future Plans
   2.15 GW Pharmaceuticals
       2.15.1 GW Pharmaceuticals Details
       2.15.2 GW Pharmaceuticals Major Business
       2.15.3 GW Pharmaceuticals Botanical Drug Product and Solutions
       2.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 GW Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Botanical Drug Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Botanical Drug by Company Revenue
       3.2.2 Top 3 Botanical Drug Players Market Share in 2022
       3.2.3 Top 6 Botanical Drug Players Market Share in 2022
   3.3 Botanical Drug Market: Overall Company Footprint Analysis
       3.3.1 Botanical Drug Market: Region Footprint
       3.3.2 Botanical Drug Market: Company Product Type Footprint
       3.3.3 Botanical Drug Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Botanical Drug Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Botanical Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Botanical Drug Consumption Value Market Share by Application (2018-2023)
   5.2 Global Botanical Drug Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Botanical Drug Consumption Value by Type (2018-2029)
   6.2 North America Botanical Drug Consumption Value by Application (2018-2029)
   6.3 North America Botanical Drug Market Size by Country
       6.3.1 North America Botanical Drug Consumption Value by Country (2018-2029)
       6.3.2 United States Botanical Drug Market Size and Forecast (2018-2029)
       6.3.3 Canada Botanical Drug Market Size and Forecast (2018-2029)
       6.3.4 Mexico Botanical Drug Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Botanical Drug Consumption Value by Type (2018-2029)
   7.2 Europe Botanical Drug Consumption Value by Application (2018-2029)
   7.3 Europe Botanical Drug Market Size by Country
       7.3.1 Europe Botanical Drug Consumption Value by Country (2018-2029)
       7.3.2 Germany Botanical Drug Market Size and Forecast (2018-2029)
       7.3.3 France Botanical Drug Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Botanical Drug Market Size and Forecast (2018-2029)
       7.3.5 Russia Botanical Drug Market Size and Forecast (2018-2029)
       7.3.6 Italy Botanical Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Botanical Drug Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Botanical Drug Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Botanical Drug Market Size by Region
       8.3.1 Asia-Pacific Botanical Drug Consumption Value by Region (2018-2029)
       8.3.2 China Botanical Drug Market Size and Forecast (2018-2029)
       8.3.3 Japan Botanical Drug Market Size and Forecast (2018-2029)
       8.3.4 South Korea Botanical Drug Market Size and Forecast (2018-2029)
       8.3.5 India Botanical Drug Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Botanical Drug Market Size and Forecast (2018-2029)
       8.3.7 Australia Botanical Drug Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Botanical Drug Consumption Value by Type (2018-2029)
   9.2 South America Botanical Drug Consumption Value by Application (2018-2029)
   9.3 South America Botanical Drug Market Size by Country
       9.3.1 South America Botanical Drug Consumption Value by Country (2018-2029)
       9.3.2 Brazil Botanical Drug Market Size and Forecast (2018-2029)
       9.3.3 Argentina Botanical Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Botanical Drug Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Botanical Drug Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Botanical Drug Market Size by Country
       10.3.1 Middle East & Africa Botanical Drug Consumption Value by Country (2018-2029)
       10.3.2 Turkey Botanical Drug Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Botanical Drug Market Size and Forecast (2018-2029)
       10.3.4 UAE Botanical Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Botanical Drug Market Drivers
   11.2 Botanical Drug Market Restraints
   11.3 Botanical Drug Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Botanical Drug Industry Chain
   12.2 Botanical Drug Upstream Analysis
   12.3 Botanical Drug Midstream Analysis
   12.4 Botanical Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Botanical Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Botanical Drug Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Buchang Pharmaceuticals Company Information, Head Office, and Major Competitors
   Table 6. Buchang Pharmaceuticals Major Business
   Table 7. Buchang Pharmaceuticals Botanical Drug Product and Solutions
   Table 8. Buchang Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Buchang Pharmaceuticals Recent Developments and Future Plans
   Table 10. China TCM Company Information, Head Office, and Major Competitors
   Table 11. China TCM Major Business
   Table 12. China TCM Botanical Drug Product and Solutions
   Table 13. China TCM Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. China TCM Recent Developments and Future Plans
   Table 15. Tsumura Company Information, Head Office, and Major Competitors
   Table 16. Tsumura Major Business
   Table 17. Tsumura Botanical Drug Product and Solutions
   Table 18. Tsumura Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Tsumura Recent Developments and Future Plans
   Table 20. Schwabe Company Information, Head Office, and Major Competitors
   Table 21. Schwabe Major Business
   Table 22. Schwabe Botanical Drug Product and Solutions
   Table 23. Schwabe Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Schwabe Recent Developments and Future Plans
   Table 25. Tong Ren Tang Company Information, Head Office, and Major Competitors
   Table 26. Tong Ren Tang Major Business
   Table 27. Tong Ren Tang Botanical Drug Product and Solutions
   Table 28. Tong Ren Tang Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Tong Ren Tang Recent Developments and Future Plans
   Table 30. Jumpcan Pharmaceutical Company Information, Head Office, and Major Competitors
   Table 31. Jumpcan Pharmaceutical Major Business
   Table 32. Jumpcan Pharmaceutical Botanical Drug Product and Solutions
   Table 33. Jumpcan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Jumpcan Pharmaceutical Recent Developments and Future Plans
   Table 35. Guangzhou Baiyunshan Pharmaceutical Company Information, Head Office, and Major Competitors
   Table 36. Guangzhou Baiyunshan Pharmaceutical Major Business
   Table 37. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
   Table 38. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
   Table 40. Yunnan Baiyao Company Information, Head Office, and Major Competitors
   Table 41. Yunnan Baiyao Major Business
   Table 42. Yunnan Baiyao Botanical Drug Product and Solutions
   Table 43. Yunnan Baiyao Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Yunnan Baiyao Recent Developments and Future Plans
   Table 45. Tasly Holding Group Company Information, Head Office, and Major Competitors
   Table 46. Tasly Holding Group Major Business
   Table 47. Tasly Holding Group Botanical Drug Product and Solutions
   Table 48. Tasly Holding Group Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Tasly Holding Group Recent Developments and Future Plans
   Table 50. Bionorica Se Company Information, Head Office, and Major Competitors
   Table 51. Bionorica Se Major Business
   Table 52. Bionorica Se Botanical Drug Product and Solutions
   Table 53. Bionorica Se Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Bionorica Se Recent Developments and Future Plans
   Table 55. Huarun 999 Company Information, Head Office, and Major Competitors
   Table 56. Huarun 999 Major Business
   Table 57. Huarun 999 Botanical Drug Product and Solutions
   Table 58. Huarun 999 Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Huarun 999 Recent Developments and Future Plans
   Table 60. Taiji Company Information, Head Office, and Major Competitors
   Table 61. Taiji Major Business
   Table 62. Taiji Botanical Drug Product and Solutions
   Table 63. Taiji Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Taiji Recent Developments and Future Plans
   Table 65. Weleda Company Information, Head Office, and Major Competitors
   Table 66. Weleda Major Business
   Table 67. Weleda Botanical Drug Product and Solutions
   Table 68. Weleda Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 69. Weleda Recent Developments and Future Plans
   Table 70. Kwangdong Company Information, Head Office, and Major Competitors
   Table 71. Kwangdong Major Business
   Table 72. Kwangdong Botanical Drug Product and Solutions
   Table 73. Kwangdong Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 74. Kwangdong Recent Developments and Future Plans
   Table 75. GW Pharmaceuticals Company Information, Head Office, and Major Competitors
   Table 76. GW Pharmaceuticals Major Business
   Table 77. GW Pharmaceuticals Botanical Drug Product and Solutions
   Table 78. GW Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 79. GW Pharmaceuticals Recent Developments and Future Plans
   Table 80. Global Botanical Drug Revenue (USD Million) by Players (2018-2023)
   Table 81. Global Botanical Drug Revenue Share by Players (2018-2023)
   Table 82. Breakdown of Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 83. Market Position of Players in Botanical Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 84. Head Office of Key Botanical Drug Players
   Table 85. Botanical Drug Market: Company Product Type Footprint
   Table 86. Botanical Drug Market: Company Product Application Footprint
   Table 87. Botanical Drug New Market Entrants and Barriers to Market Entry
   Table 88. Botanical Drug Mergers, Acquisition, Agreements, and Collaborations
   Table 89. Global Botanical Drug Consumption Value (USD Million) by Type (2018-2023)
   Table 90. Global Botanical Drug Consumption Value Share by Type (2018-2023)
   Table 91. Global Botanical Drug Consumption Value Forecast by Type (2024-2029)
   Table 92. Global Botanical Drug Consumption Value by Application (2018-2023)
   Table 93. Global Botanical Drug Consumption Value Forecast by Application (2024-2029)
   Table 94. North America Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
   Table 95. North America Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
   Table 96. North America Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
   Table 97. North America Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
   Table 98. North America Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
   Table 99. North America Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
   Table 100. Europe Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
   Table 101. Europe Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
   Table 102. Europe Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
   Table 103. Europe Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
   Table 104. Europe Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
   Table 105. Europe Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
   Table 106. Asia-Pacific Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
   Table 107. Asia-Pacific Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
   Table 108. Asia-Pacific Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
   Table 109. Asia-Pacific Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
   Table 110. Asia-Pacific Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
   Table 111. Asia-Pacific Botanical Drug Consumption Value by Region (2024-2029) & (USD Million)
   Table 112. South America Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
   Table 113. South America Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
   Table 114. South America Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
   Table 115. South America Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
   Table 116. South America Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
   Table 117. South America Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
   Table 118. Middle East & Africa Botanical Drug Consumption Value by Type (2018-2023) & (USD Million)
   Table 119. Middle East & Africa Botanical Drug Consumption Value by Type (2024-2029) & (USD Million)
   Table 120. Middle East & Africa Botanical Drug Consumption Value by Application (2018-2023) & (USD Million)
   Table 121. Middle East & Africa Botanical Drug Consumption Value by Application (2024-2029) & (USD Million)
   Table 122. Middle East & Africa Botanical Drug Consumption Value by Country (2018-2023) & (USD Million)
   Table 123. Middle East & Africa Botanical Drug Consumption Value by Country (2024-2029) & (USD Million)
   Table 124. Botanical Drug Raw Material
   Table 125. Key Suppliers of Botanical Drug Raw Materials

List of Figures

   Figure 1. Botanical Drug Picture
   Figure 2. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Botanical Drug Consumption Value Market Share by Type in 2022
   Figure 4. Prescription Drug
   Figure 5. OTC
   Figure 6. Global Botanical Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. Botanical Drug Consumption Value Market Share by Application in 2022
   Figure 8. Cardiovascular Picture
   Figure 9. Tumor Picture
   Figure 10. Respiratory System Picture
   Figure 11. Others Picture
   Figure 12. Global Botanical Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Botanical Drug Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Botanical Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Botanical Drug Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Botanical Drug Consumption Value Market Share by Region in 2022
   Figure 17. North America Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Botanical Drug Revenue Share by Players in 2022
   Figure 23. Botanical Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Botanical Drug Market Share in 2022
   Figure 25. Global Top 6 Players Botanical Drug Market Share in 2022
   Figure 26. Global Botanical Drug Consumption Value Share by Type (2018-2023)
   Figure 27. Global Botanical Drug Market Share Forecast by Type (2024-2029)
   Figure 28. Global Botanical Drug Consumption Value Share by Application (2018-2023)
   Figure 29. Global Botanical Drug Market Share Forecast by Application (2024-2029)
   Figure 30. North America Botanical Drug Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Botanical Drug Consumption Value Market Share by Application (2018-2029)
   Figure 32. North America Botanical Drug Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Botanical Drug Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Botanical Drug Consumption Value Market Share by Application (2018-2029)
   Figure 38. Europe Botanical Drug Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Botanical Drug Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Botanical Drug Consumption Value Market Share by Application (2018-2029)
   Figure 46. Asia-Pacific Botanical Drug Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Botanical Drug Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Botanical Drug Consumption Value Market Share by Application (2018-2029)
   Figure 55. South America Botanical Drug Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Botanical Drug Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Botanical Drug Consumption Value Market Share by Application (2018-2029)
   Figure 60. Middle East and Africa Botanical Drug Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Botanical Drug Consumption Value (2018-2029) & (USD Million)
   Figure 64. Botanical Drug Market Drivers
   Figure 65. Botanical Drug Market Restraints
   Figure 66. Botanical Drug Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Botanical Drug in 2022
   Figure 69. Manufacturing Process Analysis of Botanical Drug
   Figure 70. Botanical Drug Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source